Tiziana Life Sciences PLC TLSA · Stock Open Tiziana Life Sciences PLC in new tab
Tiziana Life Sciences PLC Analysis (TLSA)
Is Tiziana Life Sciences PLC a good investment? Tiziana Life Sciences PLC (TLSA) is currently trading at 1.15 USD.
Earnings Schedule: Tiziana Life Sciences PLC is expected to release its next earnings report on Oct. 7, 2026. The market consensus estimate for Forward EPS is -0.20.
Investor FAQ
Does Tiziana Life Sciences PLC pay a dividend?
No, it does not currently pay a dividend.
What asset class is Tiziana Life Sciences PLC?
Tiziana Life Sciences PLC is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Oct. 7, 2026. The company currently has a trailing EPS of -0.16.
Company Profile
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 29, 2019 | 2.000000 |
| July 31, 2020 | 2.500000 |
Community Discussion